Saccharomyces boulardii (Portuguese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Saccharomyces boulardii" in Portuguese language version.

refsWebsite

Global rank Portuguese rank

15nih.gov

4^th place

8^th place

12doi.org

2^nd place

4^th place

1wiley.com

222^nd place

196^th place

1ama-assn.org

3,257^th place

4,674^th place

ama-assn.org

jama.ama-assn.org

McFarland L, Surawicz C, Greenberg R (1994). «A randomised placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease». J Am Med Assoc. 271: 1913–8

doi.org

dx.doi.org

Malgoire JY, Bertout S, Renaud F, Bastide JM, Mallié M (2005). «Typing of Saccharomyces cerevisiae clinical strains by using microsatellite sequence polymorphism». J. Clin. Microbiol. 43 (3): 1133–7. PMID 15750073. doi:10.1128/JCM.43.3.1133-1137.2005
Vandenplas Y (1999). «Bacteria and yeasts in the treatment of acute and chronic infectious diarrhea. Part II: Yeasts». Clin. Microbiol. Infect. 5 (7): 389–395. PMID 11853563. doi:10.1111/j.1469-0691.1999.tb00162.x ^{[ligação inativa]}
Kurugöl Z, Koturoğlu G (2005). «Effects of Saccharomyces boulardii in children with acute diarrhoea». Acta Paediatr. 94 (1): 44–7. PMID 15858959. doi:10.1080/08035250410022521
Guslandi M, Mezzi G, Sorghi M, Testoni PA (2000). «Saccharomyces boulardii in maintenance treatment of Crohn's disease». Dig. Dis. Sci. 45 (7): 1462–4. PMID 10961730. doi:10.1023/A:1005588911207
Guslandi M, Giollo P, Testoni PA (2003). «A pilot trial of Saccharomyces boulardii in ulcerative colitis». Eur J Gastroenterol Hepatol. 15 (6): 697–8. PMID 12840682. doi:10.1097/01.meg.0000059138.68845.06
Kotowska M, Albrecht P, Szajewska H (2005). «Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial». Aliment. Pharmacol. Ther. 21 (5): 583–90. PMID 15740542. doi:10.1111/j.1365-2036.2005.02356.x
Czerucka D, Rampal P (1999). «Effect of Saccharomyces boulardii on cAMP- and Ca2+ -dependent Cl- secretion in T84 cells». Dig. Dis. Sci. 44 (11): 2359–68. PMID 10573387. doi:10.1023/A:1026689628136
Thomas S, Przesdzing I, Metzke D, Schmitz J, Radbruch A, Baumgart DC (2009). «Saccharomyces boulardii inhibits lipopolysaccharide-induced activation of human dendritic cells and T cell proliferation». Clin Exp Immunol. 155: 78 Em português: "S. boulardii inibe a ativação induzida por LPS das células dendríticas e a proliferação de células "T". PMID 19161443. doi:10.1111/j.1365-2249.2009.03878.x
Buts JP, Bernasconi P, Van Craynest MP, Maldague P, De Meyer R (1986). «Response of human and rat small intestinal mucosa to oral administration of Saccharomyces boulardii». Pediatr. Res. 20 (2): 192–6. PMID 3080730. doi:10.1203/00006450-198602000-00020
Zaouche A, Loukil C, De Lagausie P; et al. (2000). «Effects of oral Saccharomyces boulardii on bacterial overgrowth, translocation, and intestinal adaptation after small-bowel resection in rats». Scand. J. Gastroenterol. 35 (2): 160–5. PMID 10720113. doi:10.1080/003655200750024326
Buts JP, Bernasconi P, Vaerman JP, Dive C (1990). «Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii». Dig. Dis. Sci. 35 (2): 251–6. PMID 2302983. doi:10.1007/BF01536771
Muñoz P, Bouza E, Cuenca-Estrella M; et al. (2005). «Saccharomyces cerevisiae fungemia: an emerging infectious disease». Clin. Infect. Dis. 40 (11): 1625–34. PMID 15889360. doi:10.1086/429916

nih.gov

ncbi.nlm.nih.gov

Malgoire JY, Bertout S, Renaud F, Bastide JM, Mallié M (2005). «Typing of Saccharomyces cerevisiae clinical strains by using microsatellite sequence polymorphism». J. Clin. Microbiol. 43 (3): 1133–7. PMID 15750073. doi:10.1128/JCM.43.3.1133-1137.2005
Vandenplas Y (1999). «Bacteria and yeasts in the treatment of acute and chronic infectious diarrhea. Part II: Yeasts». Clin. Microbiol. Infect. 5 (7): 389–395. PMID 11853563. doi:10.1111/j.1469-0691.1999.tb00162.x ^{[ligação inativa]}
Kurugöl Z, Koturoğlu G (2005). «Effects of Saccharomyces boulardii in children with acute diarrhoea». Acta Paediatr. 94 (1): 44–7. PMID 15858959. doi:10.1080/08035250410022521
Guslandi M, Mezzi G, Sorghi M, Testoni PA (2000). «Saccharomyces boulardii in maintenance treatment of Crohn's disease». Dig. Dis. Sci. 45 (7): 1462–4. PMID 10961730. doi:10.1023/A:1005588911207
Guslandi M, Giollo P, Testoni PA (2003). «A pilot trial of Saccharomyces boulardii in ulcerative colitis». Eur J Gastroenterol Hepatol. 15 (6): 697–8. PMID 12840682. doi:10.1097/01.meg.0000059138.68845.06
McFarland LV, Surawicz CM, Greenberg RN; et al. (1995). «Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo». Am. J. Gastroenterol. 90 (3): 439–48. PMID 7872284
Kotowska M, Albrecht P, Szajewska H (2005). «Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial». Aliment. Pharmacol. Ther. 21 (5): 583–90. PMID 15740542. doi:10.1111/j.1365-2036.2005.02356.x
Castagliuolo I, Riegler MF, Valenick L, LaMont JT, Pothoulakis C (1999). «Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa». Infect. Immun. 67 (1): 302–7. PMID 9864230
Gedek BR (1999). «Adherence of Escherichia coli serogroup O 157 and the Salmonella typhimurium mutant DT 104 to the surface of Saccharomyces boulardii». Mycoses. 42 (4): 261–4. PMID 10424093
Czerucka D, Rampal P (1999). «Effect of Saccharomyces boulardii on cAMP- and Ca2+ -dependent Cl- secretion in T84 cells». Dig. Dis. Sci. 44 (11): 2359–68. PMID 10573387. doi:10.1023/A:1026689628136
Thomas S, Przesdzing I, Metzke D, Schmitz J, Radbruch A, Baumgart DC (2009). «Saccharomyces boulardii inhibits lipopolysaccharide-induced activation of human dendritic cells and T cell proliferation». Clin Exp Immunol. 155: 78 Em português: "S. boulardii inibe a ativação induzida por LPS das células dendríticas e a proliferação de células "T". PMID 19161443. doi:10.1111/j.1365-2249.2009.03878.x
Buts JP, Bernasconi P, Van Craynest MP, Maldague P, De Meyer R (1986). «Response of human and rat small intestinal mucosa to oral administration of Saccharomyces boulardii». Pediatr. Res. 20 (2): 192–6. PMID 3080730. doi:10.1203/00006450-198602000-00020
Zaouche A, Loukil C, De Lagausie P; et al. (2000). «Effects of oral Saccharomyces boulardii on bacterial overgrowth, translocation, and intestinal adaptation after small-bowel resection in rats». Scand. J. Gastroenterol. 35 (2): 160–5. PMID 10720113. doi:10.1080/003655200750024326
Buts JP, Bernasconi P, Vaerman JP, Dive C (1990). «Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii». Dig. Dis. Sci. 35 (2): 251–6. PMID 2302983. doi:10.1007/BF01536771
Muñoz P, Bouza E, Cuenca-Estrella M; et al. (2005). «Saccharomyces cerevisiae fungemia: an emerging infectious disease». Clin. Infect. Dis. 40 (11): 1625–34. PMID 15889360. doi:10.1086/429916

wiley.com

www3.interscience.wiley.com

Vandenplas Y (1999). «Bacteria and yeasts in the treatment of acute and chronic infectious diarrhea. Part II: Yeasts». Clin. Microbiol. Infect. 5 (7): 389–395. PMID 11853563. doi:10.1111/j.1469-0691.1999.tb00162.x ^{[ligação inativa]}